CoChat

YAP and TAZ orchestrate adaptive resistance to KRAS inhibitors

Mira, Alessia, Ambrogio, Chiara · 2023 · Nature Cancer

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1038/s43018-023-00580-5

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 15 references

Research works printed but not linked: 1

  1. Piccolo, S., Panciera, T., Contessotto, P. & Cordenonsi, M. Nat. Cancer 4, 9–26 (2023).

Cited by

See all 10

Metadata

Authors
Mira, A., & Ambrogio, C.
Affiliations
University of Turin (IT)
Corresponding author
Ambrogio, Chiara
Venue
Nature Cancer
Published
2023-06-27
Volume
4
Issue
6
Pages
784-786
ISSN
2662-1347 (ISSN-L)
OpenAlex
W4382240796
Cited by
10
References
15
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 1
FWCI
1.45
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
YAP, TAZ, KRAS inhibitors, adaptive drug resistance, mutant KRAS, Hippo signaling pathway, therapeutic target
MeSH terms
Transcription Factors, Proto-Oncogene Proteins p21(ras), Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: YAP and TAZ orchestrate adaptive resistance to KRAS inhibitors. https://app.cochat.ai/papers/10.1038/s43018-023-00580-5
The paper
Mira, A., & Ambrogio, C. (2023). YAP and TAZ orchestrate adaptive resistance to KRAS inhibitors. Nature Cancer. https://doi.org/10.1038/s43018-023-00580-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.